These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 17308162

  • 1. The cardiovascular effects of selective estrogen receptor modulators.
    Christodoulakos GE, Lambrinoudaki IV, Botsis DC.
    Ann N Y Acad Sci; 2006 Dec; 1092():374-84. PubMed ID: 17308162
    [Abstract] [Full Text] [Related]

  • 2. [Selective estrogen receptor modulators (SERMs) in the practice].
    Nagykálnai T.
    Magy Onkol; 2002 Dec; 46(2):165-75. PubMed ID: 12202896
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
    Gielen SC, Burger CW, Kühne LC, Hanifi-Moghaddam P, Blok LJ.
    J Soc Gynecol Investig; 2005 Oct; 12(7):e55-67. PubMed ID: 16202921
    [Abstract] [Full Text] [Related]

  • 6. Selective estrogen receptor modulators prevent neointima formation after vascular injury.
    Savolainen-Peltonen H, Luoto NM, Kangas L, Häyry P.
    Mol Cell Endocrinol; 2004 Nov 30; 227(1-2):9-20. PubMed ID: 15501580
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Estrogens and SERMs in coronary heart disease.
    Regitz-Zagrosek V, Wintermantel TM, Schubert C.
    Curr Opin Pharmacol; 2007 Apr 30; 7(2):130-9. PubMed ID: 17317318
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells.
    Suuronen T, Nuutinen T, Huuskonen J, Ojala J, Thornell A, Salminen A.
    Inflamm Res; 2005 May 30; 54(5):194-203. PubMed ID: 15953991
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effects of antiosteoporotic agents on glucose and lipid metabolism and cardiovascular system].
    Fukai S.
    Clin Calcium; 2008 May 30; 18(5):677-84. PubMed ID: 18445888
    [Abstract] [Full Text] [Related]

  • 18. [Estrogen receptor and selective estrogen receptor modulators (SERMs)].
    Shioi A, Nishizawa Y.
    Nihon Rinsho; 1999 May 30; 57(5):1199-207. PubMed ID: 10361456
    [Abstract] [Full Text] [Related]

  • 19. Selective estrogen receptor modulators: an update on recent clinical findings.
    Shelly W, Draper MW, Krishnan V, Wong M, Jaffe RB.
    Obstet Gynecol Surv; 2008 Mar 30; 63(3):163-81. PubMed ID: 18279543
    [Abstract] [Full Text] [Related]

  • 20. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.
    Sumner BE, Grant KE, Rosie R, Hegele-Hartung Ch, Fritzemeier KH, Fink G.
    Neurosci Lett; 2007 Apr 24; 417(1):95-9. PubMed ID: 17398000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.